Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sodium-dependent phosphate transport protein 1 (NPT1), encoded by the SLC17A1 gene, is an integral membrane protein primarily expressed in the renal proximal tubules, where it is responsible for the sodium-dependent reabsorption of inorganic phosphate from urine into blood[1]. It also plays a significant role in urate transport and is involved in the regulation of uric acid levels[1]. Mutations or dysfunctions in SLC17A1 are associated with disorders such as hyperuricemia and uric acid nephrolithiasis[1]. As a member of the solute carrier (SLC) family 17, NPT1 acts as an organic anion transporter and is part of the major facilitator superfamily[5]. This transporter is considered a potential therapeutic target for diseases related to phosphate and urate metabolism[1].
Inhibition of sodium-dependent phosphate reabsorption; Modulation of urate excretion in the kidney
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sodium-dependent phosphate transport protein 1 (NPT1).